Companies: 10,795·Total market cap: $144.5T
Lantheus Holdings, Inc.

Lantheus Holdings, Inc.

LNTHNASDAQHealthcare● Active
$100.01
$-0.97(-0.96%)
Market Cap$6.5B
P/E Ratio
52W High$103.89
52W Low$47.25

Lantheus Holdings, Inc. (LNTH) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · LNTH · as of Sep 30, 2025

Ownership Breakdown

Institutions 100%
Insiders 10.35%
Public 0%

437

Institutional Holders

▼ 69 vs Q2

$3.66B

Total Inst. Value

▼ $2.98B vs Q2

65.11M

Shares Outstanding

freeFloat 89.65%

71.70M

13F Shares Held

▼ 9.83M vs Q2

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

LNTH largest shareholders · institutional ownership

Q3 2025 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

BLACKROCK, INC.

in vitro & in vivo diagnostic substances

8.27M12.06%

12.06%

$423.95BNov 12, 2025 267.7K

VANGUARD GROUP INC

in vitro & in vivo diagnostic substances

6.95M10.15%

10.15%

$356.59BNov 7, 2025 115.3K

JANUS HENDERSON GROUP PLC

in vitro & in vivo diagnostic substances

6.68M9.76%

9.76%

$342.86BNov 14, 2025 254.2K

FMR LLC

in vitro & in vivo diagnostic substances

4.20M6.13%

6.13%

$215.37BNov 13, 2025 820.1K

MORGAN STANLEY

in vitro & in vivo diagnostic substances

3.88M5.66%

5.66%

$198.91BMay 27, 2026 3.14M

FARALLON CAPITAL MANAGEMENT LLC

in vitro & in vivo diagnostic substances

3.48M5.08%

5.08%

$178.35BFeb 17, 2026 3.25M

STATE STREET CORP

in vitro & in vivo diagnostic substances

2.50M3.64%

3.64%

$128.07BNov 14, 2025 61.6K

GEODE CAPITAL MANAGEMENT, LLC

in vitro & in vivo diagnostic substances

1.75M2.56%

2.56%

$90.00BNov 12, 2025 22.4K

DIMENSIONAL FUND ADVISORS LP

in vitro & in vivo diagnostic substances

1.37M2.00%

2.00%

$70.32BNov 12, 2025 12.0K

REINHART PARTNERS, INC.

in vitro & in vivo diagnostic substances

1.35M1.97%

1.97%

$69.13BOct 28, 2025 55.9K

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q3 2025 vs prior quarter

Q3 2025

Net institutional sentimentBullish — more buying than selling

22

Increased

+7.43M shares

2

New Positions

first time holders

24

Decreased

−8.62M shares

0

Sold Out

fully exited

Net shares change (top 50)

1.19M

+7.43M / −8.62M

Net new holders

+0

2 new / 0 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

LNTH insider trading · insider activity

Source: SEC Form 4

4

Buy transactions

4

Sell transactions

1.00

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

McHugh Julie

director

May 14, 2026Award4,13730.1KForm 4 ↗

Morrow Phuong Khanh

director

May 14, 2026Award4,1377.2KForm 4 ↗

Maeusli Heinz Christoph

director

May 14, 2026Award4,13730.0KForm 4 ↗

LENO SAM R

director

May 14, 2026Award4,13767.2KForm 4 ↗

Pruden Gary J

director

May 14, 2026Award4,1376.7KForm 4 ↗

Baylor-Henry Minnie

director

May 14, 2026Award4,13714.0KForm 4 ↗

Ber Gerard

director

May 14, 2026Award4,13727.5KForm 4 ↗

Thrall James H

director

May 14, 2026Award4,13739.9KForm 4 ↗

EASTLAND JULIA MARIE

director

May 14, 2026Award4,1378.0KForm 4 ↗

Niedzwiecki Daniel

See Remarks

Apr 17, 2026Tax Withhold1,911$83.82$160.2K117.5KForm 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Lantheus Holdings, Inc. (LNTH) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 10.35%, while retail and public investors account for the remaining 0.00%.

The largest institutional shareholder of Lantheus Holdings, Inc. is BLACKROCK, INC., holding approximately 8.27 million shares — equal to 12.06% of outstanding shares — as of September 30, 2025.

A total of 437 institutional investors currently hold LNTH stock, with a combined institutional value of approximately $3.66 billion as of the most recent 13F filing period.

Frequently asked questions

LNTH ownership

Lantheus Holdings, Inc. (LNTH) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is BLACKROCK, INC. with a 12.06% stake. Company insiders hold 10.35%. Data sourced from SEC Form 13F as of September 30, 2025.

who owns LNTH stockLNTH ownership structureSEC Form 13F institutional holdingsLNTH float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025